Menopause without hormones: The new drugs that target the hot-flash circuit

Hot flashes start in the brain’s thermostat network

Menopause lowers estrogen, but the hot flash is not simply heat produced by low estrogen. Hormonal change alters signaling in hypothalamic neurons involved in thermoregulation, narrowing the body’s comfortable temperature zone.

That biology created a new treatment target: neurokinin signaling. Instead of replacing estrogen, neurokinin antagonists act on the neural pathway that helps generate vasomotor symptoms.

A new phase 3 trial moved the field forward

In the 2025 OASIS 3 phase 3 randomized trial, elinzanetant was tested against placebo for moderate to severe vasomotor symptoms associated with menopause. The drug reduced hot-flash frequency and severity and added to a growing phase 3 evidence base for this class.

A 2025 meta-analysis covering 10 studies and 4,663 participants also found both fezolinetant and elinzanetant effective for vasomotor symptoms, with elinzanetant showing a strong efficacy signal in the pooled comparisons.

A bedside fan can still be useful for immediate comfort, but it treats the heat experience, not the neurokinin pathway.

Why this matters for women who do not use hormone therapy

Some women cannot use menopausal hormone therapy because of medical history. Others can use it but prefer not to. Historically, many nonhormonal options were medications developed for other conditions and then repurposed for hot flashes.

Neurokinin antagonists are different because they were developed around vasomotor biology. That does not automatically make them the best choice for every woman, but it expands the menu of evidence-based options.

A insulated water bottle and cooling sleep mask can make a rough night more manageable while the underlying treatment is being adjusted.

Nonhormonal is not the same as risk-free

These are prescription medications with contraindications, interactions, and monitoring considerations. Fezolinetant, for example, has specific liver-related safety requirements. Elinzanetant has its own adverse-effect profile.

The useful question is not hormones versus natural. It is which evidence-based treatment fits the symptom burden and the person’s health history.

A hot-flash diary can document frequency and severity before and after a treatment change, which makes response easier to judge.

What a useful decision looks like

Hormone decisions are rarely improved by chasing one laboratory number or one viral claim. Symptoms, goals, medical history, and the quality of the evidence all belong in the same conversation.

A useful plan also has an evaluation point. Know what outcome you are trying to change, when you will reassess it, and which side effects or new symptoms would make you contact the prescriber sooner.

The Livium recipe

Tool. Track hot-flash frequency and night-sweat disruption for two weeks.

Behavior. Ask about both hormonal and nonhormonal prescription options instead of assuming the choice is HRT or nothing.

Threshold. Medication selection and monitoring should be individualized by a qualified prescriber.

Source: Panay et al., JAMA Internal Medicine, 2025.

The treatment landscape changed quickly

For years, women who did not use estrogen often heard about cooling strategies, antidepressants, gabapentin, or simply waiting for symptoms to improve. Neurokinin-targeted drugs represent a genuinely different mechanism rather than another lifestyle workaround.

That is especially relevant when night sweats are fragmenting sleep. Treating the vasomotor event itself can be more useful than endlessly optimizing bedding around repeated awakenings.

Measure the symptom, not the marketing

Before starting a treatment, estimate how many moderate or severe hot flashes occur in a typical day and how many nights per week are disrupted. Repeat the same simple measure after several weeks.

A treatment that meaningfully reduces those events is doing something concrete. That is more useful than deciding whether a drug sounds more modern, more natural, or more hormonal.

Plan of action

• Write down the specific symptom or outcome you want to improve.
• Change one major treatment variable at a time when possible.
• Use follow-up labs or symptom tracking only when they answer a defined question.
• Do not start, stop, or change prescription hormone treatment without appropriate medical guidance.